Skip to content
Search

Latest Stories

Study estimates autism affects one in 127 globally

The estimates come from the Global Burden of Diseases (GBD) Study, the largest and most comprehensive ones to assess health loss around the world over time

Study estimates autism affects one in 127 globally

The disorder is associated with repetitive behaviour and affected social skills.

(Photo for representation: iStock)

A STUDY has estimated that one in every 127 people globally, or 6.18 crore individuals, had autism in 2021, with the neurodevelopmental condition featuring among the top 10 causes of non-fatal health burden in youth aged under 20 years.

The disorder is associated with repetitive behaviour and affected social skills. Signs, which can begin to show as early as 12 months of age, include poor non-verbal communication, such as avoiding eye contact and not responding to their name.


Published in the Lancet Psychiatry journal, the results showed that globally, autism cases among men were over twice of those in women -- 1,065 cases for every 100,000 men and 508 for every 100,000 women.

The estimates come from the Global Burden of Diseases (GBD) Study, the largest and most comprehensive ones to assess health loss around the world over time, according to the Institute for Health Metrics and Evaluation, University of Washington, US, which coordinates it.

"An estimated 61.8 million individuals (one in every 127 people) were on the autism spectrum globally in 2021," the authors wrote.

Regions such as high-income Asia Pacific, including Japan, revealed the highest prevalence (1,560 per 100,000 population), while Tropical Latin America and Bangladesh reported the lowest, researchers said.

The findings underscored the importance of early detection and support to autistic young people and their caregivers globally, the authors said.

They also called for efforts to improve accuracy of the study's findings, including a better understanding of how autism prevalence differs with geography.

"The work presented here can guide future research efforts, and importantly, decisions concerning allocation of health services that better address the needs of all autistic individuals," the authors wrote.

(PTI)

More For You

Asian community

Menopause is a universal transition - one every woman will experience in her lifetime

iStock

Breaking the silence: Why Asian women must talk about menopause

Kiran Singh

For many women in the Asian community, the journey through perimenopause and menopause is still shrouded in silence, confusion, and, at times, shame. It’s often seen as something we just have to “put up with” quietly, as though struggling through it alone is a badge of honour. But the truth is, menopause is a universal transition - one every woman will experience in her lifetime - and it is time we start talking about it, especially within our cultural communities where silence often masks suffering.

We all go through it - so why don’t we talk about it?

Menopause doesn’t arrive overnight. For most women, it begins subtly during perimenopause, which can start as early as your late 30s or early 40s and last for several years. According to the NHS and the National Institute for Health and Care Excellence (NICE), over 30 recognised symptoms of perimenopause range from hot flushes and night sweats to anxiety, low mood, brain fog, and joint pain.

Keep ReadingShow less
Great guide to building healthy eating habits

Good nutrition is the foundation of an active lifestyle

Great guide to building healthy eating habits

Nesreen G and Jayeeta Dutta

PHYSICAL exercise is important when it comes to fitness, but what we fuel our body with plays an equally vital role in achieving sustainable results.

The key to long-term fitness success is developing mindful eating habits that nourish the body and soul, enhance performance and help maintain a healthy lifestyle. This does not necessarily mean following a restrictive diet or complicated meal plans. It is about finding a sustainable balance that works for you.

Keep ReadingShow less
The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
MRI

Individuals with certain metabolic conditions may be more prone to this process

Getty

MRI injection linked to rare deadly health risk, study finds

A new study has raised concerns over the use of a common chemical injected during MRI scans, suggesting it may contribute to a potentially fatal complication in rare cases.

Researchers from the University of New Mexico have found that gadolinium – a toxic rare earth metal used in MRI contrast agents – can interact with oxalic acid found in many foods to form nanoparticles in human tissues. These particles could potentially lead to serious health problems affecting organs such as the kidneys.

Keep ReadingShow less
Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less